» Articles » PMID: 24378553

Short-term and Long-term Outcomes After Gastrectomy for Gastric Cancer in Patients with Chronic Kidney Disease

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2014 Jan 1
PMID 24378553
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of chronic kidney disease (CKD) is increasing, which might be an obstacle to various aspects of gastric cancer treatment, such as perisurgical management and postsurgical follow-up. The present study aimed to evaluate the short- and long-term surgical outcomes following gastrectomy in patients with CKD.

Methods: We retrospectively analyzed surgical complications and prognosis of patients with gastric cancer. These patients were divided into three groups according to the glomerular filtration rate (GFR): 49 patients with severe CKD (GFR < 29 ml/min/1.73 m(2)), 128 with mild CKD (GFR 30-59), and 798 in the controls (GFR ≥ 60).

Results: The incidences of anastomotic leakage and intraabdominal abscess in the mild and severe CKD groups were higher than that in the control group. The incidences of wound infection, cardiovascular and pulmonary events, and in-hospital mortality in the severe CKD group were higher than those in the other two groups. Severe surgical complications were associated with co-morbidities other than CKD, serum albumin level, estimated blood loss, surgery duration in the mild and severe CKD group. The 3-year overall survival rates for the severe CKD, mild CKD, and control groups were 48.6, 80.9, and 85.0 %, respectively, indicating significant differences between the severe CKD group and other two groups.

Conclusions: Patients with severe CKD show an increased risk of morbidity and mortality following gastrectomy, and their prognosis is usually poor. Studies with a large cohort are essential to refine the risk stratification for gastrectomy in this high-risk population.

Citing Articles

Impact of Preoperative Handgrip Strength on Postoperative Outcome after Radical Gastrectomy for Gastric Cancer Patients.

Matsui R, Inaki N, Tsuji T, Momosaki R, Fukunaga T J Clin Med. 2022; 11(23).

PMID: 36498702 PMC: 9737860. DOI: 10.3390/jcm11237129.


Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection.

Sakamoto Y, Shimada S, Kamiyama T, Sugiyama K, Asahi Y, Nagatsu A World J Gastrointest Surg. 2022; 14(7):670-684.

PMID: 36158275 PMC: 9353748. DOI: 10.4240/wjgs.v14.i7.670.


Survival benefits of gastrectomy compared to conservative observation for older patients with resectable gastric cancer: a propensity score matched analysis.

Ito S, Ohgaki K, Kawazoe T, Wang H, Nakamura T, Maehara S Langenbecks Arch Surg. 2022; 407(6):2281-2292.

PMID: 35486150 DOI: 10.1007/s00423-022-02511-x.


Impact of chronic kidney disease stage on morbidity after gastrectomy for gastric cancer.

Suzuki S, Kanaji S, Urakawa N, Takiguchi G, Hasegawa H, Yamashita K Ann Gastroenterol Surg. 2021; 5(4):519-527.

PMID: 34337301 PMC: 8316737. DOI: 10.1002/ags3.12441.


Impact of chronic kidney disease on the short- and long-term outcomes of laparoscopic gastrectomy for gastric cancer patients.

Sakurai K, Kubo N, Tamamori Y, Aomatsu N, Nishii T, Tachimori A PLoS One. 2021; 16(4):e0250997.

PMID: 33930090 PMC: 8087092. DOI: 10.1371/journal.pone.0250997.


References
1.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

2.
. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14(2):101-12. DOI: 10.1007/s10120-011-0041-5. View

3.
Jaber B . Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int. 2005; 67(6):2508-19. DOI: 10.1111/j.1523-1755.2005.00364.x. View

4.
Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-100. DOI: 10.1111/j.1523-1755.2005.00365.x. View

5.
. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004; 43(5 Suppl 1):S1-290. View